Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah A Martin

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Cell Death & Disease|April 15, 2021
Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancerVera L Silva, Jayeta Saxena, Francesco Nicolini, et al.
Iscience|February 28, 2023
Microtubule-associated proteins MAP7 and MAP7D1 promote DNA double-strand break repair in the G1 cell cycle phaseArlinda Dullovi, Meryem Ozgencil, Vinothini Rajvee, et al.
EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.
Journal of Lipid Research|July 3, 2015
Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial functionTrisha J Grevengoed, Sarah A Martin, Lalage Katunga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2016
Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient CellsDelphine Guillotin, Philip Austin, Rumena Begum, et al.
Neoplasia (New York, N.Y.)|July 12, 2025
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expressionKirsten Brooksbank, Charlotte Smith, Eleni Maniati, et al.
Diseases of the Colon and Rectum|June 7, 2024
Patient Satisfaction With Long-term Sacral Neuromodulation for Fecal Incontinence: Experience From a Single Tertiary CenterSarah A Martin, Alexander D O'Connor, Deepak Selvakumar, et al.
Communications Biology|February 4, 2022
Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapyJoseph I Hoare, Bleona Osmani, Emily A O'Sullivan, et al.
Cancer Cell|March 16, 2010
DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1Sarah A Martin, Nuala McCabe, Michelle Mullarkey, et al.
Journal of Lipid Research|January 22, 2018
Altered eicosanoid production and phospholipid remodeling during cell cultureToshiaki Okuno, Miguel A Gijón, Simona Zarini, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|April 15, 2021
Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancerVera L Silva, Jayeta Saxena, Francesco Nicolini, et al.
Iscience|February 28, 2023
Microtubule-associated proteins MAP7 and MAP7D1 promote DNA double-strand break repair in the G1 cell cycle phaseArlinda Dullovi, Meryem Ozgencil, Vinothini Rajvee, et al.
EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.
Journal of Lipid Research|July 3, 2015
Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial functionTrisha J Grevengoed, Sarah A Martin, Lalage Katunga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2016
Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient CellsDelphine Guillotin, Philip Austin, Rumena Begum, et al.
Neoplasia (New York, N.Y.)|July 12, 2025
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expressionKirsten Brooksbank, Charlotte Smith, Eleni Maniati, et al.
Diseases of the Colon and Rectum|June 7, 2024
Patient Satisfaction With Long-term Sacral Neuromodulation for Fecal Incontinence: Experience From a Single Tertiary CenterSarah A Martin, Alexander D O'Connor, Deepak Selvakumar, et al.
Communications Biology|February 4, 2022
Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapyJoseph I Hoare, Bleona Osmani, Emily A O'Sullivan, et al.
Cancer Cell|March 16, 2010
DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1Sarah A Martin, Nuala McCabe, Michelle Mullarkey, et al.
Journal of Lipid Research|January 22, 2018
Altered eicosanoid production and phospholipid remodeling during cell cultureToshiaki Okuno, Miguel A Gijón, Simona Zarini, et al.
Pageof 8